Millions of people worldwide are affected by heart valve disease, a significant public health concern.

The company’s innovative approach aims to improve patient outcomes and quality of life.

The Prevalence of Heart Valve Disease

Heart valve disease is a significant public health concern, affecting millions of people worldwide.

The Problem with Current Heart Valve Treatments

Traditional heart valve treatments often require open-heart surgery, which carries significant risks and complications. The most common treatment is the mechanical valve replacement, but it has its drawbacks. Mechanical valves are made from synthetic materials and can cause blood clots, require lifelong anticoagulation therapy, and lead to calcification and wear over time.

The Need for Minimally Invasive Solutions

The need for minimally invasive solutions has become increasingly evident in the medical field. These approaches aim to reduce recovery time, minimize scarring, and decrease the risk of complications. In the context of heart valve treatments, a minimally invasive solution could revolutionize the way we approach valve repair and replacement.

Capstan Medical’s Innovative Approach

Capstan Medical is pioneering a novel approach that combines heart valve implants with advanced catheter technology. This innovative solution aims to overcome the limitations of current treatments by providing a minimally invasive alternative. The company’s technology has the potential to:

How It Works

The Capstan Medical solution involves the use of a catheter to deliver a novel heart valve implant. This implant is designed to be biocompatible and durable, with a unique surface that promotes tissue ingrowth and reduces the risk of calcification.

Clinical Trials and Expansion Plans

Capstan Medical is taking a proactive approach to validate the effectiveness of its technology by conducting clinical trials. These trials will serve as the foundation for the company’s future growth and expansion plans.